Letters 483
Table 3 Cytotoxic activities of compounds 1–5 against HeLa and KB cell lines.
Compound
IC50a (µM)
HeLa
Compound
IC50a (µM)
HeLa
KB
KB
1c
2c
3c
9.7 1.0
4.7 0.4
4c
5c
> 100
> 100
> 100
32.2 3.0
> 100
> 100
99.6 8.3
4.0 0.3
> 100
Etoposideb
10.0 0.9
a IC50 is defined as the concentration of drug required to inhibit cell growth by 50% compared with untreated control. It is expressed as mean SD of at least three determinations.
b Reference control (> 98%). c The purity (%) of tested compound exceeded 90%
group, values of C-1 and C-1′ at δC 135.3 and 132.5 in compound 4
accounted for the appearances of equatorial and axial guaiacyl
groups. The NOESY cross-peak was observed between H-7 (δH
4.79) and H-8′ (δH 2.84). Thus, the relative configuration could
be proposed as 7,8-cis-8,8′-cis-7′,8′-trans. The CD spectrum of
compound 4 was identical with episesartemin which has the ab-
solute configuration 7R,8R,8′R,7′S [21]. Therefore, the aglycone of
compound 4 was (+) epipinoresinol. On acid hydrolysis, 4 af-
forded D-glucose. The anomeric protons of glucoses at δH 4.88
(1H, d, J = 7.1 Hz) and 4.87 (1H, d, J = 7.0 Hz), respectively, showed
HMBC correlations with the aromatic C-atoms at C-4 (δC 145.5)
and C-4′ (δC 146.0). Accordingly, compound 4 was established as
epipinoresinol-4, 4′-di-O-β-D-glucopyranoside.
284 (+ 27.0); UV (MeOH): λmax (log ε) = 208 (2.54), 230 (1.34),
280 (0.65) nm; IR (KBr): νmax = 3419, 2936, 1607, 1517, 1274,
1157, 1121, 1083, 1032 cm−1; 1H‑NMR (300 MHz, DMSO-d6) data,
13
"
"
see l Table 1; C‑NMR (75 MHz, DMSO-d6) data, see l Table 2;
(+) ESI‑MS: m/z 413 [M + Na]+, 429 [M + K]+; (−) ESI‑MS: m/z 389
[M – H]−, 425 [M + Cl]−; HR‑ESI‑MS: m/z 413.1562 [M + Na]+
(calcd. for C21H26O7Na+, 413.1576).
Sinolignan C (3): Amorphous powder; [α]2D5 − 10.0 (c 0.3, MeOH);
CD (c = 1.6 g/L, MeOH) Δ ε (nm) no Cotton effect; UV (MeOH):
λmax (log ε) = 208 (1.82), 228 (0.50), 278 (0.16) nm; IR (KBr):
ν
max = 3410, 2928, 1619, 1520, 1271, 1221, 1095, 1043 cm−1
;
H‑NMR (300 MHz, DMSO-d6) data, see l Table 1; 13C‑NMR
1
"
"
(75 MHz, DMSO-d6) data, see l Table 2; (+) ESI‑MS: m/z 561 [M
All isolated compounds were evaluated for cytotoxic activities
against human uterine cervical adenocarcinoma (HeLa) and hu-
+ Na]+, 577 [M + K]+; (−) ESI‑MS: m/z 537 [M – H]−, 573 [M + Cl]−;
HR‑ESI‑MS: m/z 561.1945 [M + Na]+ (calcd. for C26H34O12Na+,
561.1948).
"
man oral squamous carcinoma (KB) cell lines (l Table 3). Com-
pounds 1 and 2 showed cytotoxicity and compounds 3, 4, and 5
displayed no cytotoxicity against the HeLa cell line. Compound 1
displayed cytotoxicity against the KB cell line and was more cyto-
toxic than etoposide. Compound 2 is the stereoisomer of 1, and
the variation of cytotoxicity between them indicated a critical
stereochemistry requirement. Compound 1, which is the first re-
ported example of 8.8′-trans,7.O.9′ monotetrafuran lignan exhib-
iting cytotoxicity in the KB cell line, represents a novel analogue
as an antitumor lead compound for SAR and lead optimization
studies.
Epipinoresinol-4,4′-di-O-β‑D-glucopyranoside (4): Amorphous
powder; [α]2D5 − 25.0 (c 0.3, MeOH); CD (c = 1.8 g/L, MeOH) Δ ε
(nm) 230 (+ 1.1), 238 (+ 0.8), 254 (− 1.0), 286 (+ 0.5); UV (MeOH):
λ
max (log ε) = 208 (2.46), 228 (1.10), 278 (0.36) nm; IR (KBr): νmax =
3420, 2928, 1631, 1514, 1273, 1223, 1160, 1077, 1045 cm−1
;
1
H‑NMR (300 MHz, DMSO-d6) data, see l Table 1; 13C‑NMR
"
"
(75 MHz, DMSO-d6) data, see l Table 2; (+) ESI‑MS: m/z 705 [M +
Na]+; (−) ESI‑MS: m/z 681 [M – H]−, 717 [M + Cl]−, 727 [M + HCOO]−;
HR‑ESI‑MS: m/z 705.2370 [M + Na]+ (calcd. for C32H42O16Na+,
705.2371).
Materials and Methods
Supporting information
!
General experimental procedures, detailed extraction/isolation
of compounds, NMR and CD spectra of new compounds, as well
as protocols for cell culture and cytotoxicity assays, along with
the determination of the absolute configurations of the sugar
moieties are available as Supporting Information.
The plant material, purchased from Yuntian Medicinal Material
Corporation, was cultivated in Deqin, Yunnan province, Peopleʼs
Republic of China, in September 2008, and was identified as the
roots and rhizomes of Sinopodophyllum emodi (Wall.) Ying by
Professor Qishi Sun of the Shenyang Pharmaceutical University,
according to the Chinese Traditional Medicine Dictionary [22]. A
voucher specimen (SE 20081009) was deposited in the Depart-
ment of Natural Products Chemistry, Shenyang Pharmaceutical
University, Shenyang, Peopleʼs Republic of China.
Acknowledgements
!
The authors wish to thank Professor Qishi Sun (Shenyang Phar-
maceutical University, Shenyang, Peopleʼs Republic of China) for
identification of the plant material. This work was supported by
the National Natural Science Foundation of China (No.
30873363), Program of Science Foundation of Tianjin
(08JCYBJC070000), and Major Program of Science Foundation of
Tianjin 09ZCKFSH01700).
(−)-Tanegool-7′-methyl ether (1): Sticky oil; [α]2D5 − 19.4 (c 0.14,
CHCl3); CD (c = 1.2 g/L, MeOH) Δ ε (nm) 228 (+ 54.9), 258 (− 7.6),
284 (+ 18.5); UV (MeOH): λmax (log ε) = 208 (2.73), 230 (1.82),
280 (0.81) nm; IR (KBr): νmax = 3420, 2935, 1604, 1516, 1273,
1158, 1123, 1057, 1034 cm−1; 1H‑NMR (300 MHz, DMSO-d6) data,
13
"
"
see l Table 1; C‑NMR (75 MHz, DMSO-d6) data, see l Table 2;
(+) ESI‑MS: m/z 413 [M + Na]+, 429 [M + K]+; (−) ESI‑MS: m/z 389
[M – H]−, 425 [M + Cl]−; HR‑ESI‑MS: m/z 413.1574 [M + Na]+
(calcd. for C21H26O7Na+, 413.1576).
Conflict of Interest
!
There are no conflicts of interest among all authors.
(+)-7′-Methoxylariciresinol (2): Sticky oil; [α]2D5 + 9.0 (c 0.07,
CHCl3); CD (c = 1.3 g/L, MeOH) Δ ε (nm) 228 (+ 73.3), 258 (− 4.0),
Sun Y-J et al. Four New Cytotoxic… Planta Med 2012; 78: 480–484